ID
43233
Beschreibung
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia; ODM derived from: http://clinicaltrials.gov/show/NCT02034227
Link
http://clinicaltrials.gov/show/NCT02034227
Stichworte
Versionen (3)
- 03.08.15 03.08.15 - Julian Varghese
- 03.08.15 03.08.15 - Julian Varghese
- 20.09.21 20.09.21 -
Hochgeladen am
20. September 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Acute Myeloid Leukemia NCT02034227
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
Beschreibung
Exclusion Criteria
Beschreibung
are eligible for any standard therapy known to be life prolonging or life saving
Datentyp
boolean
Beschreibung
have diagnosis of aml french-american-british (fab) classification (fab) m3 (acute promyelocytic leukemia (apl))
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0457329
Beschreibung
are receiving concurrent chemotherapy, radiotherapy, immunotherapy, biological or hormonal treatment for cancer.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C1531518
- UMLS CUI [5]
- C0279025
Beschreibung
have undergone anticancer therapy including chemotherapy (except for hydroxycarbamide at a maximum daily dose of 3000 mg), endocrine therapy, immunotherapy, or the use of other investigational agents within 4 weeks before study entry.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C0279025
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C0020402
Beschreibung
prior radiation therapy with volume of bone marrow treated over 25%.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0005953
- UMLS CUI [1,3]
- C0439165
Beschreibung
use of immunosuppressive therapy, including systemic steroids within 7 days before the first dose of sg2000.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0455630
- UMLS CUI [2]
- C0149783
Beschreibung
hyperleukocytosis (blast counts >30 000/mm3).
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3805210
Beschreibung
history of allogeneic stem cell or solid organ transplantation.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0029216
- UMLS CUI [2]
- C2242529
Beschreibung
positive serology for human immunodeficiency virus (hiv), hepatitis b or hepatitis c or have hiv-aids, or active hepatitis b or c.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C0744837
- UMLS CUI [3]
- C0850489
- UMLS CUI [4]
- C0001175
Beschreibung
history of other invasive malignancy within 3 years except for cervical carcinoma in situ, nonmelanomatous carcinoma of the skin or ductal carcinoma in situ of the breast that has been surgically cured.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0677898
- UMLS CUI [2]
- C0007099
- UMLS CUI [3,1]
- C0007114
- UMLS CUI [3,2]
- C1518408
Beschreibung
have any coexisting medical condition that will substantially increase the risk associated with the subject's participation in the study.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0012634
Beschreibung
have psychiatric disorders or altered mental status precluding understanding of the informed consent process and/or completion of necessary studies.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0004936
Beschreibung
have persistent grade 2 or greater toxicities from any cause (except alopecia or peripheral neuropathy).
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2826262
- UMLS CUI [2]
- C0002170
- UMLS CUI [3]
- C0031117
Beschreibung
are pregnant or breast-feeding.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Ähnliche Modelle
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
C0205269 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
C0001779 (UMLS CUI [3])
C0278787 (UMLS CUI [4,1])
C0332293 (UMLS CUI [4,2])
C0059985 (UMLS CUI [4,3])
C0023434 (UMLS CUI [5,1])
C0332293 (UMLS CUI [5,2])
C0002073 (UMLS CUI [5,3])
C0879626 (UMLS CUI [1,2])
C0002170 (UMLS CUI [2])
C0442874 (UMLS CUI [3])
C0332298 (UMLS CUI [1,2])
C0020402 (UMLS CUI [1,3])
C0232805 (UMLS CUI [2])
C0430064 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1531518 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0020402 (UMLS CUI [4])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2])
C2242529 (UMLS CUI [2])
C0744837 (UMLS CUI [2])
C0850489 (UMLS CUI [3])
C0001175 (UMLS CUI [4])
C0007099 (UMLS CUI [2])
C0007114 (UMLS CUI [3,1])
C1518408 (UMLS CUI [3,2])
C1549479 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
C1549479 (UMLS CUI [1,2])
C0004936 (UMLS CUI [1,3])
C0002170 (UMLS CUI [2])
C0031117 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
Keine Kommentare